- Home
- Advocacy
- Latest News and Practice Data
- AMA House of Delegates advances key priorities
At the 2026 Annual Meeting of the American Medical Association (AMA) House of Delegates, several policies were adopted.
The impact: Pathology priorities continue to gain traction through coordinated advocacy at the AMA.
- The AMA adopted policy addressing Medicare Administrative Contractor (MAC) and local coverage determination (LCD) processes, including CAP-initiated amendments calling on AMA support of federal legislation to improve the LCD process.
- Policy supporting standardized oversight and transparency for CLIA-exempt toxicology laboratories was adopted, with CAP-supported amendments to ensure clarity and understanding around the concerns.
- The AMA also adopted policy, sponsored by the CAP and other laboratory organizations, recognizing the clinical laboratory workforce shortage and supporting efforts to strengthen training and education programs.
The context: All three resolutions are now AMA policy, reflecting ongoing collaboration across specialty societies and advocacy channels.
What’s next: We will share more detailed coverage from the meeting in next week’s newsletter.